Archives

  • 2019-10
  • 2019-11
  • 2020-03
  • 2020-07
  • 2020-08
  • 2021-03
  • br Acknowledgements Dutch Cancer Society grant UL br

    2019-11-11


    Acknowledgements—Dutch Cancer Society (grant UL2015-7665)
    SUPPLEMENTARY MATERIALS
    Supplementary material associated with this Conessine article can be found in the online version at doi:10.1016/j.ultra smedbio.2019.04.020.
    REFERENCES
    Allen VB, Gurusamy KS, Takwoingi Y, Kalia A, Davidson BR. Diag-nostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer. Cochrane Database Syst Rev 2016;7 CD009323.
    Campbell F, Smith RA, Whelan P, Sutton R, Raraty M, Neoptolemos JP, Ghaneh P. Classification of R1 resections for pancreatic cancer: The prognostic relevance of tumour involvement within 1 mm of a resection margin. Histopathology 2009;55:277–283.
    de Werra C, Quarto G, Aloia S, Perrotta S, Del Giudice R, Di Filippo G, Furino E, Amato B, Benassai G. The use of intraoperative ultra-sound for diagnosis and stadiation in pancreatic head neoforma-tions. Int J Surg 2015;21:S55–S58.
    Donahue TR, Isacoff WH, Hines OJ, Tomlinson JS, Farrell JJ, Bhat YM, Garon E, Clerkin B, Reber HA. Downstaging chemotherapy and alteration in the classic computed tomography/magnetic reso-nance imaging signs of vascular involvement in patients with pan-creaticobiliary malignant tumors: influence on patient selection for surgery. Arch Surg 2011;146:836–843.  Volume 45, Number 8, 2019
    D’Onofrio M, Vecchiato F, Faccioli N, Falconi M, Pozzi Mucelli R. Ultrasonography of the pancreas. 7. Intraoperative imaging. Abdom Imaging 2007;32:200–206.
    DPCG. 2012DPCG-definities resectabiliteit pancreascarcinoom (PRE-OPANC trial, DPCG 2012). Available at: http://www.dpcg.nl/ images/criteria_resectabiliteit.pdf. Feldman MK, Gandhi NS. Imaging evaluation of pancreatic cancer. Surg Clin North Am 2016;96:1235–1256.
    Ghaneh P, Kleeff J, Halloran CM, Raraty M, Jackson R, Melling J, Jones O, Palmer DH, Cox TF, Smith CJ, O’Reilly DA, Izbicki JR, Scarfe AG, Valle JW, McDonald AC, Carter R, Tebbutt NC, Goldstein D, Padbury R, Shannon J, Dervenis C, Glimelius B, Deakin M, Antho-ney A, Lerch MM, Mayerle J, Olah A, Rawcliffe CL, Campbell F, Strobel O, Buchler MW, Neoptolemos JP. European Study Group for Pancreatic Cancer. The impact of positive resection margins on survival and recurrence following resection and adjuvant chemother-apy for pancreatic ductal adenocarcinoma. Ann Surg 2017;269:520– 529.
    Giovinazzo F, Turri G, Katz MH, Heaton N, Ahmed I. Meta-analysis of benefits of portal-superior mesenteric vein resection in pancreatic resection for ductal adenocarcinoma. Br J Surg 2016;103:179–191.
    Ichikawa T, Erturk SM, Sou H, Nakajima H, Tsukamoto T, Motosugi U, Araki T. MDCT of pancreatic adenocarcinoma: Optimal imag-ing phases and multiplanar reformatted imaging. AJR Am J Roent-genol 2006;187:1513–1520.
    Iqbal S, Friedel D, Gupta M, Ogden L, Stavropoulos SN. Endoscopic-ultrasound-guided fine-needle aspiration and the role of the cytopa-thologist in solid pancreatic lesion diagnosis. Patholog Res Int 2012;2012 317167.
    Katz MH, Fleming JB, Bhosale P, Varadhachary G, Lee JE, Wolff R, Wang H, Abbruzzese J, Pisters PW, Vauthey JN, Charnsangavej C, Tamm E, Crane CH, Balachandran A. Response of borderline resectable pancreatic cancer to neoadjuvant therapy is cycads not reflected by radiographic indicators. Cancer 2012;118:5749–5756.
    Kim KS, Kwon J, Kim K, Chie EK. Impact of resection margin dis-tance on survival of pancreatic cancer: A systematic review and meta-analysis. Cancer Res Treat 2016;49:824–833.
    Kolesnik O, Lukashenko A, Shudrak A, Golovko T, Lavryk G, Hurale-vych J. Intraoperative ultrasonography in pancreatic surgery: Stag-ing and resection guidance. Exp Oncol 2015;37:285–291.